Literature DB >> 28275932

Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks In Modern Day.

Natalie D Collins1, Alan D T Barrett2.   

Abstract

PURPOSE OF REVIEW: Live attenuated 17D vaccine is considered one of the safest and efficacious vaccines developed to date. This review highlights what is known and the gaps in knowledge of vaccine-induced protective immunity. RECENT
FINDINGS: Recently, the World Health Organization modifying its guidance from 10-year booster doses to one dose gives lifelong protection in most populations. Nonetheless, there are some data suggesting immunity, though protective, may wane over time in certain populations and more research is needed to address this question. Despite having an effective vaccine to control yellow fever, vaccine shortages were identified during outbreaks in 2016, eventuating the use of a fractional-dosing campaign in the Democratic Republic of the Congo. Limited studies hinder identification of the underlying mechanism(s) of vaccine longevity; however, concurrent outbreaks during 2016 provide an opportunity to evaluate vaccine immunity following fractional dosing and insights into vaccine longevity in populations where there is limited information.

Entities:  

Keywords:  Angola; Democratic Republic of Congo; Flavivirus; Fractional dosing; Vaccine; Yellow fever

Year:  2017        PMID: 28275932      PMCID: PMC6008154          DOI: 10.1007/s11908-017-0566-9

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  37 in total

1.  High fidelity of yellow fever virus RNA polymerase.

Authors:  Konstantin V Pugachev; Farshad Guirakhoo; Simeon W Ocran; Fred Mitchell; Megan Parsons; Caroline Penal; Soheila Girakhoo; Svetlana O Pougatcheva; Juan Arroyo; Dennis W Trent; Thomas P Monath
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

Review 2.  Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?

Authors:  Alan D T Barrett; Dirk E Teuwen
Journal:  Curr Opin Immunol       Date:  2009-06-10       Impact factor: 7.486

3.  Long-lasting stem cell-like memory CD8+ T cells with a naïve-like profile upon yellow fever vaccination.

Authors:  Silvia A Fuertes Marraco; Charlotte Soneson; Laurène Cagnon; Philippe O Gannon; Mathilde Allard; Samia Abed Maillard; Nicole Montandon; Nathalie Rufer; Sophie Waldvogel; Mauro Delorenzi; Daniel E Speiser
Journal:  Sci Transl Med       Date:  2015-04-08       Impact factor: 17.956

Review 4.  The yellow fever 17D virus as a platform for new live attenuated vaccines.

Authors:  Myrna C Bonaldo; Patrícia C Sequeira; Ricardo Galler
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

Review 5.  Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.

Authors:  Eduardo Gotuzzo; Sergio Yactayo; Erika Córdova
Journal:  Am J Trop Med Hyg       Date:  2013-09       Impact factor: 2.345

6.  Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults.

Authors:  Maria Luiza Silva; Marina Angela Martins; Luçandra Ramos Espírito-Santo; Ana Carolina Campi-Azevedo; Denise Silveira-Lemos; José Geraldo Leite Ribeiro; Akira Homma; Erna Geessien Kroon; Andréa Teixeira-Carvalho; Silvana Maria Elói-Santos; Olindo Assis Martins-Filho
Journal:  Vaccine       Date:  2010-08-21       Impact factor: 3.641

7.  The changing epidemiology of dengue in China, 1990-2014: a descriptive analysis of 25 years of nationwide surveillance data.

Authors:  Shengjie Lai; Zhuojie Huang; Hang Zhou; Katherine L Anders; T Alex Perkins; Wenwu Yin; Yu Li; Di Mu; Qiulan Chen; Zike Zhang; Yanzi Qiu; Liping Wang; Honglong Zhang; Linjia Zeng; Xiang Ren; Mengjie Geng; Zhongjie Li; Andrew J Tatem; Simon I Hay; Hongjie Yu
Journal:  BMC Med       Date:  2015-04-28       Impact factor: 8.775

8.  Resurgence of Yellow Fever in Angola, 2015-2016.

Authors:  Antoinette A Grobbelaar; Jacqueline Weyer; Naazneen Moolla; Petrus Jansen van Vuren; Francisco Moises; Janusz T Paweska
Journal:  Emerg Infect Dis       Date:  2016-10-15       Impact factor: 6.883

Review 9.  Phylogeographic reconstruction of African yellow fever virus isolates indicates recent simultaneous dispersal into east and west Africa.

Authors:  Andrew Beck; Hilda Guzman; Li Li; Brett Ellis; Robert B Tesh; Alan D T Barrett
Journal:  PLoS Negl Trop Dis       Date:  2013-03-14

10.  17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study.

Authors:  Reinaldo M Martins; Maria de Lourdes S Maia; Roberto Henrique G Farias; Luiz Antonio B Camacho; Marcos S Freire; Ricardo Galler; Anna Maya Yoshida Yamamura; Luiz Fernando C Almeida; Sheila Maria B Lima; Rita Maria R Nogueira; Gloria Regina S Sá; Darcy A Hokama; Ricardo de Carvalho; Ricardo Aguiar V Freire; Edson Pereira Filho; Maria da Luz Fernandes Leal; Akira Homma
Journal:  Hum Vaccin Immunother       Date:  2013-01-30       Impact factor: 3.452

View more
  34 in total

1.  Urine as Sample Type for Molecular Diagnosis of Natural Yellow Fever Virus Infections.

Authors:  Chantal B E M Reusken; Marjolein Knoester; Corine GeurtsvanKessel; Marion Koopmans; Daan G Knapen; Wouter F W Bierman; Suzan Pas
Journal:  J Clin Microbiol       Date:  2017-08-30       Impact factor: 5.948

2.  Oleic acid Enhances Dengue Virus But Not Dengue Virus-Like Particle Production from Mammalian Cells.

Authors:  Suwipa Ramphan; Sathiporn Suksathan; Nitwara Wikan; Puey Ounjai; Kanpong Boonthaworn; Poramate Rimthong; Tapanee Kanjanapruthipong; Suchin Worawichawong; Anan Jongkaewwattana; Nuttaporn Wongsiriroj; Duncan R Smith
Journal:  Mol Biotechnol       Date:  2017-10       Impact factor: 2.695

Review 3.  Natural-Product-Based Solutions for Tropical Infectious Diseases.

Authors:  Oyelola Adegboye; Matt A Field; Andreas Kupz; Saparna Pai; Dileep Sharma; Michael J Smout; Phurpa Wangchuk; Yide Wong; Claire Loiseau
Journal:  Clin Microbiol Rev       Date:  2021-09-08       Impact factor: 50.129

Review 4.  The science and medicine of human immunology.

Authors:  Bali Pulendran; Mark M Davis
Journal:  Science       Date:  2020-09-25       Impact factor: 47.728

5.  Zika, dengue and yellow fever viruses induce differential anti-viral immune responses in human monocytic and first trimester trophoblast cells.

Authors:  Huanle Luo; Evandro R Winkelmann; Ildefonso Fernandez-Salas; Li Li; Sandra V Mayer; Rogelio Danis-Lozano; Rosa Ma Sanchez-Casas; Nikos Vasilakis; Robert Tesh; Alan D Barrett; Scott C Weaver; Tian Wang
Journal:  Antiviral Res       Date:  2018-01-10       Impact factor: 5.970

6.  CD-loop Extension in Zika Virus Envelope Protein Key for Stability and Pathogenesis.

Authors:  Emily N Gallichotte; Kenneth H Dinnon; Xin-Ni Lim; Thiam-Seng Ng; Elisa X Y Lim; Vineet D Menachery; Shee-Mei Lok; Ralph S Baric
Journal:  J Infect Dis       Date:  2017-12-05       Impact factor: 5.226

7.  SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.

Authors:  M Gordon Joyce; Wei-Hung Chen; Rajeshwer S Sankhala; Agnes Hajduczki; Paul V Thomas; Misook Choe; William Chang; Caroline E Peterson; Elizabeth Martinez; Elaine B Morrison; Clayton Smith; Aslaa Ahmed; Lindsay Wieczorek; Alexander Anderson; Rita E Chen; James Brett Case; Yifan Li; Therese Oertel; Lorean Rosado; Akshaya Ganesh; Connor Whalen; Joshua M Carmen; Letzibeth Mendez-Rivera; Christopher Karch; Neelakshi Gohain; Zuzana Villar; David McCurdy; Zoltan Beck; Jiae Kim; Shikha Shrivastava; Ousman Jobe; Vincent Dussupt; Sebastian Molnar; Ursula Tran; Chandrika B Kannadka; Michelle Zemil; Htet Khanh; Weimin Wu; Matthew A Cole; Debra K Duso; Larry W Kummer; Tricia J Lang; Shania E Muncil; Jeffrey R Currier; Shelly J Krebs; Victoria R Polonis; Saravanan Rajan; Patrick M McTamney; Mark T Esser; William W Reiley; Morgane Rolland; Natalia de Val; Michael S Diamond; Gregory D Gromowski; Gary R Matyas; Mangala Rao; Nelson L Michael; Kayvon Modjarrad
Journal:  bioRxiv       Date:  2021-05-10

8.  Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination.

Authors:  Ismael Artur da Costa-Rocha; Ketty Lysie Libardi Lira Machado; Ana Carolina Campi-Azevedo; Andréa Teixeira-Carvalho; Vanessa Peruhype-Magalhães; Sheila Maria Barbosa de Lima; Emily Hime Miranda; Gisela Freitas Trindade; Thays Zanon Casagrande; Samira Tatiyama Miyamoto; Sávio Carvalho Deotti; Rafaela Villa Real Barbosa; Priscila Costa Martins Rocha; Erica Vieira Serrano; Valquiria Garcia Dinis; Sônia Alves Gouvêa; Maria Bernadete Renoldi de Oliveira Gavi; Lidia Balarini da Silva; Ruben Horst Duque; Ana Paula Espíndula Gianordoli; Maria de Fatima Bissoli; Maria da Penha Gomes Gouvea; Lauro Ferreira da Silva Pinto-Neto; Ana Paula Neves Burian; Francieli Fontana Sutile Tardetti Fantinato; Gecilmara Salviato Pileggi; Licia Maria Henrique da Mota; Valéria Valim; Olindo Assis Martins-Filho
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

Review 9.  The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design.

Authors:  Félix A Rey; Karin Stiasny; Marie-Christine Vaney; Mariano Dellarole; Franz X Heinz
Journal:  EMBO Rep       Date:  2017-12-27       Impact factor: 8.807

10.  Development of Machine Learning Models and the Discovery of a New Antiviral Compound against Yellow Fever Virus.

Authors:  Victor O Gawriljuk; Daniel H Foil; Ana C Puhl; Kimberley M Zorn; Thomas R Lane; Olga Riabova; Vadim Makarov; Andre S Godoy; Glaucius Oliva; Sean Ekins
Journal:  J Chem Inf Model       Date:  2021-07-21       Impact factor: 6.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.